📰 Exact Sciences Corp News
Page 11 - Exact Sciences Corp News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Exact Sciences Corp. Real-time updates on events, politics, business and more.
December 1, 2021
/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS) today announced that data from the Rx for Positive Node, Endocrine Responsive Breast Cancer, or RxPONDER,...
December 1, 2021
/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS) today announced that data from the Rx for Positive Node, Endocrine Responsive Breast Cancer, or RxPONDER,...
November 23, 2021
/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a global leader in cancer diagnostics, today announced the publication of results underscoring the...
November 23, 2021
/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a global leader in cancer diagnostics, today announced the publication of results underscoring the...
October 29, 2021
/PRNewswire/ -- The "Global Liquid Biopsy Market by Circulating Biomarker, Product, Application, End User, Clinical Application, Cancer Types, Sample Type,...
October 29, 2021
/PRNewswire/ -- The "Global Liquid Biopsy Market by Circulating Biomarker, Product, Application, End User, Clinical Application, Cancer Types, Sample Type,...
October 25, 2021
/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS) today shared data from modeling analyses that demonstrate Cologuard (mt-sDNA), with its included patient...
October 25, 2021
/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS) today shared data from modeling analyses that demonstrate Cologuard (mt-sDNA), with its included patient...
October 12, 2021
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors...
August 16, 2021
/PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that Japans Ministry of Health, Labor and Welfare (MHLW) has approved the Oncotype DX...